Peptide based immunotherapy: A pivotal tool for allergy treatment

International Immunopharmacology

Volumn 19, Issue 2, 2014, Pages 391-398

  Gupta, Kriti ^a   Kumar, Sandeep ^a   Das, Mukul ^a   Dwivedi, Premendra D ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Allergens; Allergy; IgE; Immunotherapy; T cell epitopes

Indexed keywords

BEE VENOM; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PEPTIDE; T LYMPHOCYTE EPITOPE PEPTIDE; UNCLASSIFIED DRUG; WASP VENOM;

ALLERGY; CYTOKINE RESPONSE; DOMESTIC ANIMAL ALLERGY; EGG ALLERGY; GRASS POLLEN; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; JAPANESE CEDAR; MILK ALLERGY; ORAL IMMUNOTHERAPY; PEANUT ALLERGY; POLLEN ALLERGY; PRIORITY JOURNAL; REDUCTION; REGULATORY T LYMPHOCYTE; REVIEW; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY;

ALLERGENS; ALLERGY; IGE; IMMUNOTHERAPY; T-CELL EPITOPES;

ANIMALS; EPITOPES, T-LYMPHOCYTE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; PEPTIDES;

EID: 84896798572     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.01.030     Document Type: Review

References (83)

1. S. Kumar, A.K. Verma, M. Das, and P.D. Dwivedi Molecular mechanisms of IgE mediated food allergy Int Immunopharmacol 13 4 2012 432 439
2. Pawankar R, Walter G, Stephen C, Richard TH, Lockey F. Allergic diseases as a global public health issue. In: WAO White Book on Allergy 2011-2012.
3. K. Otsu, and D.M. Fleischer Therapeutics in food allergy: the current state of the art Curr Allergy Asthma Rep 12 1 2012 48 54
4. D. El-Qutob, G. Mencia, and E. Fernandez-Caldas Recent advances in immunotherapy for allergic diseases Recent Pat Inflamm Allergy Drug Discov Nov 12 2013 10.2174/1872213X07666131113111159 [Epub ahead of print]
5. K.J. Mackenzie, P.M. Fitch, M.D. Leech, A. Ilchmann, C. Wilson, and A.J. McFarlane et al. Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation Immunology 138 3 2013 258 268
6. E. Taudorf, and B. Weeke Orally administered grass pollen Allergy 38 8 1983 561 564
7. E.M. Savilahti, M. Kuitunen, M. Valori, V. Rantanen, L. Bardina, and G. Gimenez et al. Changes in IgE and IgG4 epitope binding profiles associated with the outcome of oral immunotherapy in cow's milk allergy Pediatr Allergy Immunol 2014 10.1111/pai.12186 [Epub ahead of print]
8. P. Bégin, L.C. Winterroth, T. Dominguez, S.P. Wilson, L. Bacal, and A. Mehrotra et al. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy Allergy Asthma Clin Immunol 10 1 2014 1
9. G. Passalacqua, G.W. Canonica, and I. Baiardini Pediatr Allergy Immunol 18 s18 November 2007 40 45
10. N. Rodríguez-Pérez, J. Ambriz-Moreno Mde, G.W. Canonica, and M. Penagos Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy Ann Allergy Asthma Immunol 101 3 2008 304 310
11. H. de Groot, and A. Bijl Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet Allergy 64 6 2009 963 964
12. L. Cox Sublingual immunotherapy for aeroallergens: status in the United States Allergy Asthma Proc 35 1 2014 34 42
13. K.C. Bergmann, P. Demoly, M. Worm, W.J. Fokkens, T. Carrillo, and A.I. Tabar et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis J Allergy Clin Immunol 2013 10.1016/j.jaci.2013.11.012 [pii: S0091-6749(13)01773-9, Epub ahead of print]
14. G. Senna, M. Caminati, and G.W. Canonica Safety and tolerability of sublingual immunotherapy in clinical trials and real life Curr Opin Allergy Clin Immunol 13 6 2013 656 662
15. J.F. Phillips, R.F. Lockey, R.W. Fox, D.K. Ledford, and M.C. Glaum Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine Allergy Asthma Proc 32 4 2011 288 294
16. C.A. Coop Local reactions from subcutaneous allergen immunotherapy Immunotherapy 5 11 2013 1151 1158
17. S.R. Prickett, A.L. Voskamp, T. Phan, A. Dacumos-Hill, S.I. Mannering, and J.M. Rolland et al. Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic ClinExp Allergy 43 6 2013 684 697
18. A. Verhoef, C. Alexander, A.B. Kay, and M. Larche T cell epitope immunotherapy induces a CD4 + T cell population with regulatory activity PLoS Med 2 2005 253 261
19. V.K. Kuchroo, M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, and R.A. Sobel et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy Cell 80 5 1995 707 718
20. R.J. van Neerven, T. Wikborg, G. Lund, B. Jacobsen, A. Brinch-Nielsen, and J. Arnved et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4 + T cells by inhibiting serum-IgE-facilitated allergen presentation J Immunol 163 5 1999 2944 2952
21. P.A. Wachholz, and S.R. Durham Mechanisms of immunotherapy: IgG revisited Curr Opin Allergy Clin Immunol 4 4 2004 313 318
22. Heather Secrist, Carl J. Chelen, Yan Wen, Jason D. Marshall, and Dale T. Umetsu Allergen immunotherapy decreases interleukin 4 production in CD4 + T cells from allergic individuals J Exp Med 178 6 1993 2123 2130
23. M. Jutel, W.J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U.R. Muller Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g secretion in specific allergen stimulated T cell cultures J Immunol 154 1995 4187 4194
24. J.L. Greenstein, J.P. Morgenstern, J. LaRaia, C.M. Counsell, W.H. Goodwin, and A. Lussier et al. Ragweed immunotherapy decreases T cell reactivity to recombinant Amba I.1 J Allergy Clin Immunol 89 1992 322
25. P.S. Creticos Immunologic changes associated with immunotherapy P.A. Greenberger, Immunology and allergy clinics of North America: immunotherapy of IgE mediated disorders 1992 WB Saunders Philadelphia 13 37
26. Y. Okamoto, S. Horiguchi, H. Yamamoto, S. Yonekura, and T. Hanazawa Present situation of cedar pollinosis in Japan and its immune responses Allergol Int 58 2009 155 162
27. Y. Maeda, K. Akiyama, and T. Shida A clinical study of Japanese cedar (Cryptomeria japonica) pollen-induced asthma Allergol Int 57 2008 413 417
28. K. Ozasa, K. Dejima, and H. Takenaka Prevalence of Japanese cedar pollinosis among school children in Japan Int Arch Allergy Immunol 128 2002 165 167
29. K. Masud, M. Sakaguchi, H. Saito, S. Yasueda, T. Iwabuchi, and N. Tsukui et al. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs Vet Immunol Immunopathol 102 2004 45 52
30. H. Yasueda, Y. Yui, T. Shimizu, and T. Shida Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen J Allergy Clin Immunol 71 1983 77 86
31. M. Sakaguchi, S. Inouye, M. Taniai, S. Ando, M. Usui, and T. Matuhasi Identification of the second major allergen of Japanese cedar pollen. Source Department of Microbiology, Institute of Public Health, Tokyo, Japan Allergy 45 1990 309 312
32. S. Saito, K. Hirahara, J. Kawaguchi, N. Serizawa, K. Hino, and Y. Taniguchi et al. Identification of T cell determinants in Cry j1 and Cry j2 of size suitable for peptide immunotherapy against Japanese cedar pollinosis Annu Rep Sankyo Res Lab 52 2000 49 58
33. F. Takaiwa, T. Katsube, S. Kitagawa, T. Hisago, M. Kito, and S. Utsumi Plant Sci 111 1995 39 49
34. M. Adachi, Y. Takenaka, A.B. Gidamis, B. Mikami, and S. Utsumi J Mol Biol 305 2001 291 305
35. Motohiko Suzuki, Nobuo Ohta, Wei-Ping Min, Tamami Matsumoto, Rui Min, and Xusheng Zhang et al. Immunotherapy with CpG DNA conjugated with T-cell epitope peptide of an allergenic Cry j 2 protein is useful for control of allergic conditions in mice Int Immunopharmacol 7 2007 46 54
36. Source: Allergy to pets and animals. Retrieved on 15 May 2013 from allergyclinic.co.uk
37. J.L. Ohman Jr., F.C. Lowell, and K.J. Bloch Allergens of mammalian origin, III: properties of a major feline allergen J Immunol 113 1974 1668 1677
38. W. Smith, A.J. Butler, L.A. Hazell, M.D. Chapman, A. Pomes, and D.G. Nickel et al. Fel d 4, a cat lipocalin allergen Clin Exp Allergy 34 2004 1732 1738
39. K. Ichikawa, L.D. Vailes, A. Pomes, and M.D. Chapman Identification of a novel cat allergen: cystatin Int Arch Allergy Immunol 124 2001 55 56
40. Justus Adédoyin, Hans Grönlund, Hans Oman, S.G.O. Johansson, and Marianne van Hage Cat IgA, representative of new carbohydrate cross-reactive allergens J Allergy Clin Immunol 119 3 2007 640 645
41. O.A. Duffort, J. Carreira, G. Nitti, F. Polo, and M. Lombardero Studies on the biochemical structure of the major cat allergen Felis domesticus I Mol Immunol 28 1991 301 309
42. I.J. Griffith, S. Craig, J. Pollock, X.B. Yu, J.P. Morgenstern, and B.L. Rogers Expression and genomic structure of the genes encoding FdI, the major allergen from the domestic cat Gene 113 2 1992 263 268
43. F.R. Ali, and M. Larche Peptide-based immunotherapy: a novel strategy for allergic disease Expert Rev Vaccines 4 2005 881 889
44. M. Larche Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches Pharmacol Ther 108 2005 353 361
45. C. Alexander, M. Tarzi, M. Larché, and A.B. Kay The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects Allergy 60 10 2005 1269 1274
46. F.E. Simons, M. Imada, Y. Li, W.T. Watson, and K.T. HayGlass Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects Int Immunol 8 12 1996 1937 1945
47. W.L. Oldfield, A.B. Kay, and M. Larche Allergen derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects J Immunol 167 2001 1734 1739
48. J.M. Oliver, C.L. Kepley, E. Ortega, and B.S. Wilson Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FceRI signaling pathway Immunopharmacology 48 2000 269 281
49. O. Malbec, D.C. Fong, M. Turner, V.L. Tybulewicz, J.C. Cambier, and W.H. Fridman et al. Fce Receptor I-associated lyn-dependent phosphorylation of Fcg Receptor IIB during negative regulation of mast cell activation J Immunol 160 1998 1647 1658
50. M.T. Mellerup, G.W. Hahn, L.K. Poulsen, and H. Malling Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment Clin Exp Allergy 30 10 2000 1423 1429
51. J.M. Carballido, N. Carballido-Perrig, M.K. Kägi, R.H. Meloen, B. Wüthrich, and C.H. Heusser et al. T cell epitope specificity in human allergic and non-allergic subjects to bee venom phospholipase A2 J Immunol 150 1993 3582 3591
52. K. Kuchler, M. Gmachl, M.J. Sippl, and G. Kreil Analysis of the cDNA for phospholipase A2 from honey bee venom glands Eur J Biochem 1184 1989 249 254
53. H. Mosbech Position paper: immunotherapy with hymenoptera venoms Allergy 48 Suppl. 14 1993 36 46
54. M. Jutel, U. Muller, M. Fricker, S. Rih, W. Pichler, and C. Dahinden Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils Clin Exp Allergy 26 1996 1112 1118
55. R.P. Schleimer, C.P. Derse, B. Friedmann, S. Gillis, M. Plaut, and M.L. Lichtenstein et al. Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids J Immunol 143 1989 1310 1317
56. T. Brunner, C.H. Heusser, and C.A. Dahinden Human peripheral blood basophils primed by IL-3 produces IL-4 in response to IgE receptor stimulation J Exp Med 177 1993 605 611
57. Yan Zheng, Yuanyuan Zha, and Thomas F. Gajewski Molecular regulation of T-cell anergy EMBO Rep 9 1 2008 50 55
58. M. Jutel, W.J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U.R. Müller Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures J Immunol 154 8 1995 4187 4194
59. K. Hunt, M. Valentine, A. Sobotka, A. Benton, F. Amodio, and L. Lichtenstein A controlled trial of immunotherapy in insect hypersensitivity N Engl J Med 299 1978 157 161
60. C.A. Akdis, T. Blesken, M. Akdis, S.S. Alkan, B. Wuthrich, and C.H. Heusser et al. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells J Allergy Clin Immunol 99 1997 345 353
61. K. Blaser Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production A. Sehon, K.T. HayGlass, D. Kraft, Advances in experimental medicine and biology 1996 Plenum Press New York 295 303
62. J.M. Carballido, N. Carballido-Perrig, A. Oberli-Schrammli, C.H. Heusser, and K. Blaser Regulation of IgE and IgG4 responses by allergen specific T cell clones to bee venom phospholipase A2 in vitro J Allergy Clin Immunol 93 1994 758 767
63. D.G. Brooks, and R.K. Bush Allergens and other factors important in atopic disease Leslie Carroll Grammer, Paul A. Greenberger, Patterson's allergic diseases 7th ed. 2009 Lippincott Williams & Wilkins 73 103
64. X. Basagaña, J. Sunyer, M. Kogevinas, J.P. Zock, E. Duran-Tauleria, and D. Jarvis et al. Socioeconomic status and asthma prevalence in young adults. The European Community Respiratory Health Survey Am J Epidemiol 160 2 2004 178 188
65. G. Pittner, S. Vrtala, W.R. Thomas, M. Weghofer, M. Kundi, and F. Horak et al. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens Clin Exp Allergy 34 4 2004 597 603
66. N.R. Lynch, W.R. Thomas, N.M. Garcia, M.C. Di Prisco, F.A. Puccio, and R.I. L'opez et al. Biological activity of recombinant Der p 2, Der p 5 and Der p 7 allergens of the house-dust mite Dermatophagoides pteronyssinus Int Arch Allergy Immunol 114 1 1997 59 67
67. G.J. Gleich, E.M. Zimmermann, L.L. Henderson, and J.W. Yunginger Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study J Allergy Clin Immunol 70 1982 261 271
68. R. Djurup, and O. ∅sterballe IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy: prognostic value of serum IgG subclass antibody levels early in immunotherapy Allergy 39 1984 433 441
69. H. Otsuka, A. Mezawa, M. Ohnishi, K. Okubo, H. Seki, and M. Okuda Changes in nasal metachromatic cells during allergen immunotherapy Clin Exp Allergy 21 1 1991 115 119
70. I. Kimura, Y. Tanizaki, Y. Goda, H. Komagoe, and H. Kitani Decrease in reactivity of basophils by immunotherapy with housedust extract Clin Allergy 15 1 1985 1 7
71. S.H. Sicherer, and H.A. Sampson Food allergy: epidemiology, pathogenesis, diagnosis, and treatment J Allergy Clin Immunol 2013 10.1016/j.jaci.2013.11.020 [pii: S0091-6749(13)01836-8, Epub ahead of print]
72. Donald R. Hoffman Immunochemical identification of the allergens in egg white J Allergy Clin Immunol 71 5 1983 481 486
73. M. Eggesbø, G. Botten, R. Halvorsen, and P. Magnus The prevalence of allergy to egg: a population-based study in young children Allergy 56 5 2001 403 411
74. P. Rupa, and Y. Mine Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy Allergy 67 2012 74 82
75. E. Holen, and S. Elsayed Characterization of four major allergens of hen egg-white by IEF/SDS-PAGE combined with electrophoretic transfer and IgE-immunoautoradiography Int Arch Allergy Appl Immunol 91 2 1990 136 141
76. J. Bernhisel-Broadbent, H.M. Dintzis, R.Z. Dintzis, and H.A. Sampson Allergenicity and antigenicity of chicken egg ovomucoid (Gal d III) compared with ovalbumin (Gal d I) in children with egg allergy and in mice J Allergy Clin Immunol 93 6 1994 1047 1059
77. M. Yang, C. Yang, and Y. Mine Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms Clin Exp Allergy 40 4 2010 668 678
78. S.H. Sicherer, A. Munoz-Furlong, J.H. Godbold, and H.A. Sampson US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up J Allergy Clin Immunol 125 6 2010 1322 1326
79. J.H. DeLong, K.H. Simpson, E. Wambre, E.A. James, D. Robinson, and W.W. Kwok Ara h 1-reactive T cells in individuals with peanut allergy J Allergy Clin Immunol 127 5 2011 1211-8.e3 10.1016/j.jaci.2011.02.028
80. S.R. Prickett, A.L. Voskamp, A. Dacumos-Hill, K. Symons, J.M. Rolland, and R.E. O'Hehir Ara h 2 peptides containing dominant CD4 + T-cell epitopes: candidates for a peanut allergy therapeutic J Allergy Clin Immunol 127 3 2011 [608-15.e1-5]
81. C. Sackesen, A. Assa'ad, C. Baena-Cagnani, M. Ebisawa, A. Fiocchi, and R.G. Heine et al. Cow's milk allergy as a global challenge Curr Opin Allergy Clin Immunol 11 3 2011 243 248
82. A. Fiocchi, J. Brozek, H.J. Schunemann, S.L. Bahna, A. von Berg, and K. Beyer et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines World Allergy Organ J 3 2010 57 61
83. M. Kondo, H. Kaneko, T. Fukao, K. Suzuki, H. Sakaguchi, and S. Shinoda et al. The response of bovine beta-lactoglobulin-specific T-cell clones to single amino acid substitution of T-cell core epitope Pediatr Allergy Immunol 19 7 2008 592 598